These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19907173

  • 1. Treatment and prevention of experimental autoimmune myocarditis with CD28 superagonists.
    Wang S, Liu J, Wang M, Zhang J, Wang Z.
    Cardiology; 2010; 115(2):107-13. PubMed ID: 19907173
    [Abstract] [Full Text] [Related]

  • 2. CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.
    Beyersdorf N, Hanke T, Kerkau T, Hünig T.
    Autoimmun Rev; 2006 Jan; 5(1):40-5. PubMed ID: 16338210
    [Abstract] [Full Text] [Related]

  • 3. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
    Beyersdorf N, Hanke T, Kerkau T, Hünig T.
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv91-5. PubMed ID: 16239397
    [Abstract] [Full Text] [Related]

  • 4. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
    Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hünig T, Kerkau T, Gold R.
    J Exp Med; 2005 Aug 01; 202(3):445-55. PubMed ID: 16061730
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis.
    Wei L, Wei-Min L, Cheng G, Bao-Guo Z.
    Autoimmunity; 2006 Jun 01; 39(4):289-98. PubMed ID: 16891217
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
    Tischner D, Weishaupt A, van den Brandt J, Müller N, Beyersdorf N, Ip CW, Toyka KV, Hünig T, Gold R, Kerkau T, Reichardt HM.
    Brain; 2006 Oct 01; 129(Pt 10):2635-47. PubMed ID: 16921176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.
    Exp Hematol; 2007 Mar 01; 35(3):416-25. PubMed ID: 17309822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R, Cordova C, San Román JA, Gutierrez B, Cachofeiro V, Nieto ML.
    J Mol Cell Cardiol; 2014 Jul 01; 72():250-62. PubMed ID: 24732212
    [Abstract] [Full Text] [Related]

  • 15. A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation.
    Futamatsu H, Suzuki J, Koga N, Adachi S, Kosuge H, Maejima Y, Haga T, Hirao K, Horuk R, Isobe M.
    J Mol Cell Cardiol; 2006 Jun 01; 40(6):853-61. PubMed ID: 16698032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation.
    Azuma RW, Suzuki J, Ogawa M, Futamatsu H, Koga N, Onai Y, Kosuge H, Isobe M.
    Cardiovasc Res; 2004 Dec 01; 64(3):412-20. PubMed ID: 15537494
    [Abstract] [Full Text] [Related]

  • 20. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
    Pando R, Barshack I, Raz A, Luboshits G, Haklai R, Maysel-Auslender S, Kloog Y, Keren G, George J.
    Cardiovasc Pathol; 2010 Dec 01; 19(2):94-101. PubMed ID: 19144546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.